Malin Corporation announces Poseida Therapeutics’ acquisition by Roche
LONDON: Malin Corporation plc (Euronext Growth Dublin: MLC), a company investing in innovative life sciences, announced that its investee company, Poseida Therapeutics, Inc. (NASDAQ: PSTX),...
CG Oncology goes public with $380 million IPO, Malin’s stake rises in value
LONDON, UK: CG Oncology, a biotechnology company focused on cancer immunotherapy, has launched its initial public offering (IPO) of 20 million shares at $19 per...
Malin Corporation’s investee Immunocore prices upsized Nasdaq IPO
DUBLIN: Malin Corporation notes that its investee company, Immunocore, has announced the pricing of its initial public offering (IPO) of 9.9 million American Depositary Shares...